Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Martinswerk GmbH, a subsidiary of Huber Engineered Materials, is a global leader in the production of specialty chemical products based on aluminum hydroxide and aluminum oxide. While primarily known for its flame retardants and mineral fillers used in the plastics and paper industries, the company is a critical supplier to the healthcare and pharmaceutical sectors. It produces high-purity aluminum hydroxides used as active pharmaceutical ingredients (APIs) in antacids and as essential adjuvants in various vaccine formulations. The company operates a major manufacturing and R&D site in Bergheim, Germany, serving a diverse global clientele across industrial and life science applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Martinswerk.